Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.... NEWS MEDICAL · 2 months
Montefiore and Einstein evaluate a new drug combination to fight COVID-19  NEWS MEDICAL · 1 week
Montefiore Health System Albert Einstein College of Medicine have begun the next stage of the Adaptive COVID-19 Treatment Trial (ACTT), to evaluate treatment options for people... more
Ivy Center opens new clinical trial to evaluate experimental drug cocktail for glioblastoma  NEWS MEDICAL · 7 days
The Ivy Brain Tumor Center at Barrow Neurological Institute announced that patient recruitment has opened for a new Phase 0 clinical trial... more
Clinical trial launched to evaluate experimental COVID-19 therapies  NEWS MEDICAL · 3 weeks
Clinical leaders from the University of Kentucky's Markey Cancer Center, College of Medicine and College of Pharmacy have launched a clinical trial for experimental therapies to treat patients infected with COVID-19. more
ACTG initiates clinical trial to evaluate treatment for COVID-19  NEWS MEDICAL · 3 weeks
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination... more
NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19  NEWS MEDICAL · 3 weeks
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease... more
Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19  NEWS MEDICAL · 3 weeks
A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available... more
NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19  NEWS MEDICAL · 4 weeks
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019... more
Pivotal to support new clinical trial for COVID-19 patients  NEWS MEDICAL · 4 weeks
Pivotal, a European-wide full-service CRO, has announced today that it has been contracted to provide specialized clinical research services in a clinical trial to study the efficacy and safety of... more
UCI Health to initiate clinical trial of a drug to treat critically ill COVID-19 patients  NEWS MEDICAL · 3 weeks
UCI Health will initiate a clinical study of a drug to treat critically ill COVID-19 patients who face... more
The Latest: British agency allows experimental virus drug  ABC NEWS · 1 week
Britain’s medicines agency has authorized the use of the experimental drug remdesivir for COVID-19 patients more
Cancer drug nilotinib found to be safe and well-tolerated in Alzheimer's disease clinical trial  NEWS MEDICAL · 5 days
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it... more
UCLA-led clinical trial to assess if hormone suppresser will reduce COVID-19 severity in men  NEWS MEDICAL · 3 weeks
UCLA researchers have launched a new clinical trial that uses a hormone suppresser commonly used to treat men with prostate... more
Clinical trial of COVID-19 vaccine starts in Australia  NEWS MEDICAL · 6 days
Over 100 candidate vaccines are being explored as a means of ending the COVID-19 pandemic. Eight of these have already made it to clinical trials in humans, and another 94 are in... more
New clinical trial to investigate the efficacy of ivermectin against COVID-19  NEWS MEDICAL · 3 weeks
Clínica Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, have launched a clinical trial to... more
Preventing 'cytokine storm' may ease severe COVID-19 symptoms  SCIENCE DAILY · 2 weeks
A clinical trial in people with the new coronavirus is testing a drug that may halt an overactive immune response before it ramps up. more
New study to evaluate drug combination treatment for uveitis  NEWS MEDICAL · 3 weeks
Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of... more
Modified clinical trial design to meet urgent community needs during COVID-19 pandemic  NEWS MEDICAL · 2 weeks
A new paper published online in the Annals of the American Thoracic Society describes a nimble, pragmatic and rigorous multicenter clinical trial design to... more
Clinical trial advances treatment for multiple sclerosis  NEWS MEDICAL · 7 days
Researchers conducting a clinical trial to advance the treatment of multiple sclerosis successfully applied a new drug testing methodology which allows several treatment options to be trialled at once. more
Clinical trial to test the efficacy of defibrotide medicine for reducing COVID-19 death rate  NEWS MEDICAL · 3 weeks
The Neurosciences Institute, mixed centre of the Spanish National Research Council and the Miguel Hernández University of Elche, have collaborated... more
FDA approves IND application by Octapharma USA for severe COVID-19 patients  NEWS MEDICAL · 2 weeks
The U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application submitted by Octapharma USA for a phase three clinical trial on... more
11 healthcare centers participate in clinical trial of Russian drug against novel coronavirus  NEWS MEDICAL · 3 weeks
Initially, the drug was developed to treat rheumatoid arthritis. BIOCAD developers receive regulatory authorization as part of the procedure approved by Decree... more
HVTN and HPTN initiate first clinical trial in response to COVID-19  NEWS MEDICAL · 3 weeks
The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19. more
Further evidence does not support hydroxychloroquine for patients with COVID-19  SCIENCE DAILY · 3 weeks
The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with pneumonia due to COVID-19, finds a study from France. And... more
Ruxolitinib shows promise in severe COVID-19  NEWS MEDICAL · 3 days
An anti-inflammatory drug Ruxolitinib has shown promising results in the treatment of severe coronavirus disease COVID-19. The study titled, “Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial,” was published... more
Global study to test whether antimalaria drug can prevent COVID-19 in health-care workers  NEWS MEDICAL · 2 weeks
With $9 million in philanthropic support, an international group of physicians and scientists is establishing a research network to evaluate promising therapies... more
A $10 million grant enables expansion of BCG vaccine trial against COVID-19  NEWS MEDICAL · 4 weeks
An A$10 million grant from the Bill & Melinda Gates Foundation will allow the Murdoch Children's Research Institute's clinical trial of the BCG vaccine... more
WHO: Drug Trump taking to fight COVID-19 best left to tests  ABC NEWS · 2 weeks
The World Health Organization says the science is still unclear on an anti-malaria drug that U.S. President Donald Trump is taking to try to defend against... more
Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients  NEWS MEDICAL · 2 weeks
Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus. T more
Gilead says drug helped moderately ill coronavirus patients  ABC NEWS · 2 days
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19 more
No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients, study finds  SCIENCE DAILY · 2 weeks
A new study finds that the use of chloroquine or hydroxychloroquine is linked to increased rates of mortality and heart arrhythmias among... more
MORE SCIENCE VIDEO
Antibiotic-destroying genes widespread in bacteria in soil and on people
PHYS.ORG
A mysterious company’s coronavirus papers in top medical journals may be unraveling
Science Magazine
The interconnectedness of human, animal and environmental health
PHYS.ORG
The fury in US cities is rooted in a long history of racist policing, violence and inequality
PHYS.ORG
Study shows hydroxychloroquine's harmful effects on heart rhythm
SCIENCE DAILY
Supply chain innovation can reduce coronavirus food shortages
PHYS.ORG
Video: The real risks of a pandemic
PHYS.ORG
Large droplet sorting now possible at high speeds
PHYS.ORG
Loss of land-based vertebrates is accelerating, study finds
PHYS.ORG
Hot stars are plagued by giant magnetic spots
PHYS.ORG
FRESH SCIENCE